TBRC’s market research report covers hyaluronic acid-based dermal fillers market size, hyaluronic acid-based dermal fillers market forecasts, major hyaluronic acid-based dermal fillers companies and their market share, key strategies to undertake, and more.
LONDON, Aug. 17, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research report on the hyaluronic acid-based dermal fillers market, increasing demand for non-invasive dermatology techniques is driving the growth of hyaluronic acid-based dermal fillers. Deep palpation, x-rays, and blood pressure checks are examples of non-invasive tests that require breaking the skin or entering the body. Most of the treatments are non-invasive and are done by using acid-based dermal fillers as they have minimal risks involved and give long-lasting results. For example, The American Society of Plastic Surgeons (ASPS), a society for American plastic surgeons, stated in February 2022 that each year, more than 17 million adults opt for cosmetic surgeries that include minimally invasive options such as body contouring, lasers, and injections. This demand is expected to drive the hyaluronic acid-based dermal fillers market.
Request for a sample of the global hyaluronic acid-based dermal fillers market report
The global hyaluronic acid-based dermal fillers market size is expected to grow from $3.58 billion in 2021 to $3.91 billion in 2022 at a compound annual growth rate (CAGR) of 9.5%. The global hyaluronic acid-based dermal fillers market share is expected to grow to $5.66 billion in 2026 at a CAGR of 9.7%.
Technological advancements are shaping the hyaluronic acid-based dermal fillers market. Major companies operating in the hyaluronic acid-based dermal fillers sector are focused on developing new technological solutions to strengthen their position in the hyaluronic acid-based dermal fillers market. For instance, in 2021, a new treatment called laser resurfacing treatments was introduced on the market, which is more efficient and less invasive, addressing multiple skin concerns. It uses lasers to solve all the skin problems at once, making them more appealing. Moreover, the treatment can also be used to cope with COVID-19 stress.
As per the hyaluronic acid-based dermal fillers industry report, major players in the hyaluronic acid-based dermal fillers market are Bohus Biotech AB, Allergan, Galderma Laboratories L.P, Merz Pharmaceuticals, Genzyme Corporation, Anika Therapeutics Inc, LG Life Sciences, Bio plus Co. Ltd., Sculpt Luxury Dermal Fillers Ltd, Bioxis Pharmaceutical, Sinclair Pharma, Laboratories Vivacy, Medicis Aesthetics Holdings, Inc., and Inamed Corp.
The global hyaluronic acid-based dermal fillers market analysis is segmented by product into single-phase product, duplex product; by usage into speciality and dermatology clinics, hospitals and clinics; by application: into wrinkle removal, lip augmentation, rhinoplasty, others.
North America was the largest region in the hyaluronic acid-based dermal fillers market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global hyaluronic acid-based dermal fillers market during the forecast period. The regions covered in the global hyaluronic acid-based dermal fillers market overview are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Hyaluronic Acid-Based Dermal Fillers Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provide hyaluronic acid-based dermal fillers market overviews, hyaluronic acid-based dermal fillers market analyze and forecast market size and growth for the whole market, hyaluronic acid-based dermal fillers market segments and geographies, hyaluronic acid-based dermal fillers market trends, hyaluronic acid-based dermal fillers market drivers, hyaluronic acid-based dermal fillers market restraints, hyaluronic acid-based dermal fillers market leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Not the market you are looking for? Check out some similar market intelligence reports:
Dermal Filler Global Market Report 2022 – By Filler Type (Calcium Hydroxylapatite, Hyaluronic Acid, Poly-Alkylimide, Polylactic Acid, Polymethylmethacrylate Microspheres), By Product (Biodegradable, Non-Biodegradable), By End-User (Hospital, Cosmetic Clinics, Outpatient Centres, Beauty Centres, Other End-Users), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration Of Volume Or Fullness) – Market Size, Trends, And Global Forecast 2022-2026
Cosmetic Surgery Global Market Report 2022 – By Procedure Type (Surgical Procedures, Non-Surgical Procedures, Other Procedures), By Provider (Spas And Cosmetic Surgery Centers, Hospitals And Specialty Clinics), By Gender (Male, Female), By Application (Liposuction, Eyelid And Nose Surgery, Body Contouring, Face Reconstruction, Cosmetic Implants, Other Applications), By End-User (Hospitals, Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2022-2026
Aesthetic Medicine Global Market Report 2022 – By Product (Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Tattoo Removal Devices, Thread Lift Products, Physician-Dispensed Cosmeceuticals And Skin Lighteners, Physician-Dispensed Eyelash Products, Nail Treatment Laser Devices), By Procedure Type (Invasive Procedures, Non-Invasive Procedures), By End-User (Clinics, Hospitals, And Medical Spas, Beauty Centres, Home Care) – Market Size, Trends, And Global Forecast 2022-2026
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
In this article, we discuss the 5 stocks that Warren Buffett is buying on the dip. If you want to see more stocks in this selection, click Warren Buffett is Buying the Dip on These 3 Stocks. Berkshire Hathaway’s Warren Buffett went on a buying spree despite the turmoil in the global equity markets. In […]
Shares of StoneCo (NASDAQ: STNE), a cloud-based technology platform, plummeted Friday morning after the company reported its second-quarter results, which disappointed investors, and announced yet another shift to its management team. The company reported non-GAAP (adjusted) earnings of 0.25 Brazilian reals (equivalent to $0.05), which was an increase from a loss of 0.48 reals in the year-ago quarter, but was below Wall Street's consensus estimate of about 0.57 reals, or $0.11 per share. StoneCo's revenue in the quarter was 2.3 billion reals (about $442 million), 5% higher than the company's guidance, and up 275% from the year-ago quarter.
The stock rose as much as 272% but is up about 175% as of 1:25 p.m. ET. The tech stock's gain came on the day of its initial public offering (IPO). Given the way the stock is soaring, the market apparently thinks the IPO was underpriced.
Yahoo Finance Live’s Brian Cheung and Brian Sozzi discuss why retail traders are angry at activist investor Ryan Cohen for selling his remaining stake in BBBY stock.
For investors looking to maximize their wealth by the time they retire, the following pair of beaten-down businesses that possess strong growth capabilities are a worthwhile place to start. Freelance marketplace operator Fiverr (NYSE: FVRR) was a pandemic-lockdown superstar. Although Fiverr's stock price is down 65% in 2022 and off 82% from its all-time high, the freelance shop is still growing, albeit at a slower rate as SMBs became more cautious due to rampant inflation and rising energy costs and interest rates.
A 20-year-old USC student has made a $110 million profit from trading meme stock favorite Bed Bath & Beyond, following a frenzy in Wednesday’s trading session.
MoffettNathanson Managing Director and Equity Research Analyst Robert Fishman joins Yahoo Finance Live to discuss Paramount’s streaming strategy, plans to acquire U.S. rights to the Championships League, the Paramount-Walmart streaming deal, and the outlook for streaming giants.
The past few weeks have been refreshing for Cathie Wood and fans of her style of growth stock investing. The CEO and co-founder of Ark Invest publishes the buys and sells of her firm's exchange-traded funds (ETFs) every market day, giving the public insight into her latest allocation strategies.
Verizon (VZ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
(Bloomberg) -- Warren Buffett’s Berkshire Hathaway Inc. won approval from US regulators to buy as much as 50% of Occidental Petroleum Corp. after spending months acquiring its shares. Occidental’s shares surged on news of the authorization.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide as Short-Sellers Cash In on Rate Woes: Markets WrapC
Jake Freeman cashed out his 6% stake in the meme stock after it exploded on Tuesday.
(Bloomberg) -- Billionaire Ryan Cohen pocketed a $68.1 million profit from the sale of his stake in Bed Bath & Beyond Inc., scoring a 56% gain on an investment he held for roughly seven months.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide as Short-Sellers Cash In on Rate Woes: Markets WrapCovid’s Harmful Effects on the Brain Reverberate
In this article, we discuss 10 Cathie Wood stocks to buy before the bull run starts. If you want to see more stocks preferred by Cathie Wood to load up on before the bull run begins, click 5 Cathie Wood Stocks to Buy Before the Bull Run Starts. Cathie Wood, the founder and CIO of […]
(Bloomberg) -- One big force at the center of the two-month equity rally is showing signs of fatigue. Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide as Short-Sellers Cash In on Rate Woes: Markets WrapCovid’s Harmful Effects on the Brain Reverberate Years LaterIt’s the behavior of short sellers, whose frantic efforts to unwind bearish wag
In an order made public on Friday, the Federal Energy Regulatory Commission (FERC) said that authorization was "consistent with the public interest." Neither Berkshire nor Occidental immediately responded to requests for comment. Berkshire began buying Occidental shares around the time the invasion began, and by Aug. 8 had accumulated a 20.2% stake.
One of the big reasons for investing in real estate investment trusts (REITs) is the kind of dividends many pay. While Treasury bonds are just beginning to catch up with inflation, some REITs offer better yields as long as investors are willing to accept the risks attached to owning them. Here are seven REITs with better-than-average, hard-to-ignore dividend yields: AGNC Investment Corp. (NASDAQ: AGNC) is paying 11.36% at a price of $12.57. The Bethesda, Maryland-based company specializes in res
The zany story of Bed Bath & Beyond's stock price gets zanier.
The Federal Energy Regulatory Commission filing could mean that Berkshire Hathaway will continue to increase its stake in Occidental.
Chasing best-known favorites may not be the best way to score on Meme stocks, analysts say. Meme stock ETFs can help.
Potential Cleveland-Cliffs Inc. ( NYSE:CLF ) shareholders may wish to note that the Executive VP & CFO, Celso...